Choroidal Thickness Measurements During Central Serous Chorioretinopathy (CSCR) Treatment

Completed

• Conditions: Choroidal Thickness

• Registration Number: NCT01610804
• Lead Sponsor: University Hospital Regensburg

Brief Summary

The purpose of this study is to determine changes in choroidal thickness in patients with Central Serous Chorioretinopathy (CSCR) during the first 3 months after initial diagnosis via Enhanced-Depth-Imaging-Spectral-Domain-Optical-Coherence-Tomography (EDI-OCT).

Study hypothesis: Since exudative changes in the choroid seem to constitute the primary pathology of CSCR, changes in choroidal thickness compared to healthy eyes should be present and be visible using EDI-OCT.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Primary Completion: 2011-11
• Status Verified: 2012-05
• Study Completion: 2012-05
• Study First Submitted: 2012-05-31
• Study First Submitted QC: 2012-06-01
• Last Update Submitted: 2012-06-01
• Study First Posted: 2012-06-04
• Last Update Posted: 2012-06-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

• Patients with initial diagnosis of CSCR and no treatment so far

Read More

Exclusion Criteria

• Therapy (drugs/laser) due to CSCR

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

University Hospital Regensburg; 🇩🇪 Regensburg, Bavaria, Germany